Please use this identifier to cite or link to this item:
Title: Quantitative accuracy and lesion detectability of low-dose 18F-FDG PET for lung cancer screening
Authors: Schaefferkoetter J.D.
Yan J.
Sj�holm T.
Townsend D.W.
Conti M.
Tam J.K.C. 
Soo R.A.
Tham I.
Keywords: Low dose
Lung cancer
Issue Date: 1-Mar-2017
Publisher: Society of Nuclear Medicine Inc.
Citation: Schaefferkoetter J.D., Yan J., Sj�holm T., Townsend D.W., Conti M., Tam J.K.C., Soo R.A., Tham I. (2017-03-01). Quantitative accuracy and lesion detectability of low-dose 18F-FDG PET for lung cancer screening. Journal of Nuclear Medicine 58 (3) : 399-405. ScholarBank@NUS Repository.
Abstract: Lung cancer remains responsible for more deaths worldwide than any other cancer, but recently there has been a significant shift in the clinical paradigm regarding the initial management of subjects at high risk for this disease. Low-dose CT has demonstrated significant improvements over planar x-ray screening for patient prognoses and is now performed in the United States. Specificity of this modality, however, is poor, and the additional information from PET has the potential to improve its accuracy. Routine screening requires consideration of the effective dose delivered to the patient, and this work investigates image quality of PET for low-dose conditions, in the context of lung lesion detectability. Reduced radiotracer doses were simulated by randomly discarding counts from clinical lung cancer scans acquired in list-mode. Bias and reproducibility of lesion activity values were relatively stable even at low total counts of around 5 million trues. Additionally, numeric observer models were developed and trained with the results of 2 physicians and 3 postdoctoral researchers with PET experience in a detection task; detection sensitivity of the observers was well correlated with lesion signal-to-noise ratio. The models were used prospectively to survey detectability of lung cancer lesions, and the findings suggested a lower limit around 10 million true counts for maximizing performance. Under the acquisition parameters used in this study, this translates to an effective patient dose of less than 0.4 mSv, potentially allowing a complete low-dose PET/CT lung screening scan to be obtained under 1 mSv. � Copyright 2017 by the Society of Nuclear Medicine and Molecular Imaging.
Source Title: Journal of Nuclear Medicine
ISSN: 01615505
DOI: 10.2967/jnumed.116.177592
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.